天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1)

D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1) Struktur
1848226-91-4
CAS-Nr.
1848226-91-4
Englisch Name:
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1)
Synonyma:
Dapagliflozin Citrate;Dapagliflozin(citric acid);D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1)
CBNumber:
CB310466730
Summenformel:
C27H33ClO13
Molgewicht:
601
MOL-Datei:
1848226-91-4.mol

D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1) Eigenschaften

Sicherheit

D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden

D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Cato Research Chemicals Inc. 13342851930
 3008394369@qq.com China 15726 58
  • D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid (1:1)
  • Dapagliflozin Citrate
  • Dapagliflozin(citric acid)
  • 1848226-91-4
  • C27H33ClO13
Copyright 2019 ? ChemicalBook. All rights reserved